The results presented in this report are based on antimicrobial resistance (AMR) data from invasive isolates reported to the Central Asian and European surveillance of Antimicrobial Resistance (CAESAR) network and the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2022 (data referring to 2021).
This literature review, covering the period from 2000 to January 2022, assessed the state of knowledge on biocide resistance in wild vector populations across the EU/EEA and neighbouring countries.
This report provides an overview of the main findings of the 2020–2021 harmonised AMR monitoring in Salmonella spp., Campylobacter jejuni and C. coli in humans and food-producing animals and relevant meat thereof.
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between February and August 2022.
In 2019, a total of 117 881 confirmed cases of gonorrhoea were reported by 28 EU/EEA Member States. The overall crude notification rate was 31.6 cases per 100 000 population.
In 2021, 14 560 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases the number of cases (14 550 cases) corresponds to a crude rate of 4.1 cases per 100 000 population.
In 2016–2017, the European Centre for Disease Prevention and Control (ECDC) organised the third point prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use in European long-term care facilities (LTCFs) or HALT-3.
This report covers the events and threats detected by the ECDC epidemic intelligence (EI) team in 2020 and the actions taken in relation to these findings. The objective of EI at ECDC is to rapidly detect and assess public health events of any origin to ensure EU health security as defined in ECDC’s mandate.
For 2021, 6 534 confirmed cases of STEC infection were reported by 30 EU/EEA countries (Table 1). Twenty-seven countries reported at least two confirmed cases, and three countries reported no cases. The EU/EEA notification rate was 2.2 cases per 100 000 population, representing a 37.5% increase compared with the previous year.